Autoreactive CD8 T cells in organ-specific autoimmunity: emerging targets for therapeutic intervention.
about
Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes.Neurons are MHC class I-dependent targets for CD8 T cells upon neurotropic viral infectionWest Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor HDual, HLA-B27 Subtype-dependent Conformation of a Self-peptideClonal tracking of autoaggressive T cells in polymyositis by combining laser microdissection, single-cell PCR, and CDR3-spectratype analysisRapid identification of MHC class I-restricted antigens relevant to autoimmune diabetes using retrogenic T cells.A detailed analysis of the murine TAP transporter substrate specificityDifferential Effects of Naja naja atra Venom on Immune Activity.The pathogenicity of self-antigen decreases at high levels of autoantigenicity: a computational approach.Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetesGlobal activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligoMultifunctional capsule-in-capsules for immunoprotection and trimodal imaging.Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral bloodDevelopment of new strategies to prevent type 1 diabetes: the role of animal models.A microRNA profile of human CD8(+) regulatory T cells and characterization of the effects of microRNAs on Treg cell-associated genes.Continuum model of T-cell avidity: Understanding autoreactive and regulatory T-cell responses in type 1 diabetes.Soluble peptide treatment reverses CD8 T-cell-induced disease in a mouse model of spontaneous tissue-selective autoimmunity.Pathogenic implications for autoimmune mechanisms derived by comparative eQTL analysis of CD4+ versus CD8+ T cells.T-bet controls autoaggressive CD8 lymphocyte responses in type 1 diabetes.TGF-{beta}-dependent CD103 expression by CD8(+) T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease.Human β-cell killing by autoreactive preproinsulin-specific CD8 T cells is predominantly granule-mediated with the potency dependent upon T-cell receptor avidity.The MHC class I peptide repertoire is molded by the transcriptome.High distribution of CD40 and TRAF2 in Th40 T cell rafts leads to preferential survival of this auto-aggressive population in autoimmunityMultiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood.Constitutively CD40-activated B cells regulate CD8 T cell inflammatory response by IL-10 inductionRegulation of type 1 diabetes by NKT cells.Virus-induced CD8+ T cells accelerate the onset of experimental autoimmune encephalomyelitis: implications for how viral infections might trigger multiple sclerosis exacerbations.CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope.Microbial antigen mimics activate diabetogenic CD8 T cells in NOD mice.Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models.Self-peptides prolong survival in murine autoimmunity via reduced IL-2/IL-7-mediated STAT5 signaling, CD8 coreceptor, and V alpha 2 down-regulation.Postarrest stalling rather than crawling favors CD8(+) over CD4(+) T-cell migration across the blood-brain barrier under flow in vitro.CD8(+) T cells in multiple sclerosis.Differential regulation of islet-specific glucose-6-phosphatase catalytic subunit-related protein gene transcription by Pax-6 and Pdx-1.The role of lymphocytes in the development and treatment of alopecia areata.Adoptive Transfer of mRNA-Transfected T Cells Redirected against Diabetogenic CD8 T Cells Can Prevent Diabetes.Modulation of PD-L1 and CD8 Activity in Idiopathic and Infectious Chronic Inflammatory Conditions.Enumerating autoreactive T cells in peripheral blood: a big step in diabetes prediction.HLA class I epitope discovery in type 1 diabetes.Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide.
P2860
Q24679680-B547209B-12BB-451B-A2BA-37BDB4DB7701Q27348449-48D8BDB3-B8C0-44AA-AE13-F153CE9B6047Q27477691-FBC80FE0-0568-4ADB-B54A-D06A0E9D68CFQ27642989-3FAB1E92-97AE-4278-B98C-AB224C2A9CACQ30902237-92669376-CE3B-4E86-B0BA-BF34730812FAQ33331089-5AD8F3B1-662B-4238-B073-2C0FE142199DQ33342843-57ED9401-7757-46AF-B48F-2F240D48E022Q33849987-14043F12-172B-400A-8AEF-F50EA38D7EB1Q33941941-A4866109-9D3F-4982-B69B-E5D576D2E230Q34234705-F1F3BD2A-7B79-48FA-8E75-8143579CCF33Q34287499-5AFFC32B-EA9A-4AC9-A343-6EA1A417355BQ34781329-248DA923-E0C9-42E3-81B1-22380DA0EE9AQ34830048-60AB5C06-ABC0-4F6D-8A5C-F6B592082C0AQ35622028-88A05AF3-0337-4E2E-B6A5-FA28D7596550Q35633815-E00A8104-57DE-4F16-A39C-BDF1FD196E51Q36054301-ED1CC349-315F-4D2E-8419-8E2904EF66B7Q36091144-AF68757D-9EAE-4C65-A385-CBFD962391FBQ36293782-AC34B818-CC2B-4FD0-85EB-EB33E75C8C4EQ36399438-7A07B15D-EB60-4B14-AFC9-0233F887DCD3Q36402998-AE3C02EA-36F7-4550-AA5F-61FA2251F574Q36477211-4DE2C3D7-B8F2-4A3E-AB6B-DC6936198907Q36509857-17FC0A14-452F-4C0C-BBB5-E9DAC279709DQ36572935-A847E0DF-5093-49D0-B29F-E6F65AF5A19FQ36602220-57B106E4-EBA2-4889-8A5D-7A67426747D1Q36718160-2622C12F-F214-4E3D-BEDF-BF5F55825183Q36799687-8D4FF266-2063-4B14-B46D-11ACC64E4213Q36844057-A652F686-AA89-4997-AB2D-557E7131F636Q36890836-6477AE12-8D0F-407A-B798-AF3AD1563F46Q37272130-D006D219-3C67-4342-921A-DCC0614A6C88Q37313736-3C376113-7222-480C-8F26-D14DEE0F67E8Q37316034-B968BF94-0A8D-4FA8-B285-5517A0E1D71EQ37420442-EDA020C3-430F-4AF4-A4DC-674A66052AE6Q37591260-4CF8A207-617C-4E90-9CFB-31EF99879C87Q38340376-7E34C861-A974-4E1C-BB89-04A225313DA3Q38627998-6E531E02-FDF4-4937-8415-6E3018DEE26CQ38720152-FB30749C-E722-46E3-8D07-E0AF3A3AB58AQ38756832-04BC693D-FEAA-47F7-9C60-1ACAC420B97CQ39741038-EC7718DE-C67E-4B59-B79B-095A10A3D78BQ40203831-C368D261-7B07-45BA-A64C-5B69EC52E88FQ40418904-B0C3C6D2-EF0C-45C7-B98E-BEDD7D846482
P2860
Autoreactive CD8 T cells in organ-specific autoimmunity: emerging targets for therapeutic intervention.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Autoreactive CD8 T cells in or ...... for therapeutic intervention.
@ast
Autoreactive CD8 T cells in or ...... for therapeutic intervention.
@en
Autoreactive CD8 T cells in or ...... for therapeutic intervention.
@nl
type
label
Autoreactive CD8 T cells in or ...... for therapeutic intervention.
@ast
Autoreactive CD8 T cells in or ...... for therapeutic intervention.
@en
Autoreactive CD8 T cells in or ...... for therapeutic intervention.
@nl
prefLabel
Autoreactive CD8 T cells in or ...... for therapeutic intervention.
@ast
Autoreactive CD8 T cells in or ...... for therapeutic intervention.
@en
Autoreactive CD8 T cells in or ...... for therapeutic intervention.
@nl
P50
P1433
P1476
Autoreactive CD8 T cells in or ...... s for therapeutic intervention
@en
P2093
Pere Santamaria
P356
10.1016/S1074-7613(02)00338-2
P407
P577
2002-07-01T00:00:00Z